Today in Science: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in Science.

Press releases published on June 8, 2026

Jun. 8, 2026

OUTDOOR HOLDING COMPANY TO CONDUCT FOURTH QUARTER EARNINGS CALL ON JUNE 22, 2026 AT 9:00 AM ET

Indeterminate GlobeNewswire

Jun. 8, 2026

FDH Aero Enters Next Phase of Growth Through Partnership with Bain Capital and Audax Private Equity

Indeterminate GlobeNewswire

Jun. 8, 2026

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data Supporting the Ongoing Phase 3 STOP-HAE Clinical Trial at the 2026 Annual EAACI Congress

Indeterminate GlobeNewswire

Jun. 8, 2026

Mavenir and TextNow Win Best MVNO and Industry Collaboration at MVNOs World Awards

Indeterminate GlobeNewswire

Jun. 8, 2026

Pushpay Introduces a Streamlined Customer Experience Between Pushpay and Nurture.io Platforms

Indeterminate GlobeNewswire

Jun. 8, 2026

Alkeus Pharmaceuticals Announces First Patient Dosed in Pivotal Global Phase 3 NORTHSTAR Study of Oral Gildeuretinol in Stargardt Disease

Indeterminate GlobeNewswire

Jun. 8, 2026

Nexera Technologies: Subsidiary Fort Technology Commences Trading on Nasdaq Under Ticker “FRTT” Today

Indeterminate GlobeNewswire

Jun. 8, 2026

Ambros Therapeutics Announces First Patient Dosed in Pivotal CRPS-RISE Phase 3 Clinical Trial of Neridronate in Patients with Complex Regional Pain Syndrome Type 1

Indeterminate GlobeNewswire

Jun. 8, 2026

AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress from Phase 2 Study Evaluating Ampligen® (rintatolimod) in Combination with AstraZeneca’s Imfinzi® (durvalumab) for the Treatment of Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 8, 2026

Foresight Secures $17.5 Million Strategic Investment from VisionWave at a $34 Million Valuation Post Investment to Advance AI Perception Capabilities for Defense and Security

Indeterminate GlobeNewswire

Jun. 8, 2026

Telitacicept Receives NMPA Approval for the Treatment of Sjögren’s Disease in China

Indeterminate GlobeNewswire

Jun. 8, 2026

Datanomix Brings Production-Tested AI to Automate 2026

Indeterminate GlobeNewswire

Jun. 8, 2026

Medera Expands Scientific Advisory Board with Leading Heart Failure and Cardiopulmonary Physiology Experts to Advance HFpEF Gene Therapy Program

Indeterminate GlobeNewswire

Jun. 8, 2026

Enovis Launches Spinamic® Hybrid Scoliosis Brace, Combining Corrective Performance with Improved Wearability for Children and Teens

Indeterminate GlobeNewswire

Jun. 8, 2026

Sparrow Pharmaceuticals Announces Phase 2a Data Showing Cardiometabolic Benefits of Clofutriben in Adults with Type 2 Diabetes

Indeterminate GlobeNewswire

Jun. 8, 2026

Conexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Program

Indeterminate GlobeNewswire

Jun. 8, 2026

Winners Inc. To Stream Live In-Game Prediction Markets Trading During Knicks Game 3 With President Trump Attending NBA Finals At Madison Square Garden, New York

Indeterminate GlobeNewswire

Jun. 8, 2026

Liquidia Corporation Announces Inclusion in the S&P SmallCap 600® Index

Indeterminate GlobeNewswire

Jun. 8, 2026

U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation

Indeterminate GlobeNewswire

Jun. 8, 2026

A Next-Gen Intelligence Platform Operating at the Intersection of AI, Defense Technology, and Quantum Cybersecurity

Indeterminate GlobeNewswire